 |
 |
 |
| |
Few differences in persistence and virologic outcomes across age groups among CAB+RPV LA users: Findings from the OPERA Cohort
 
|
| |
| |
IDWeek Atlanta, GA, October 19-22, 2025  
Michael Sension1, Ricky K Hsu2,3, Jennifer S. Fusco4, Laurence Brunet4, Brooke Levis4, Quateka Cochran5, Gayathri Sridhar6,
Vani Vannappagari6, Kimberley Brown6, Jean Van Wyk7, Michael Wohlfeiler8, Gregory P. Fusco4
1CAN Community Health, Fort Lauderdale, FL; 2NYU Langone Medical Center, New York, NY; 3AIDS Healthcare Foundation, New York, NY; 4Epividian, Raleigh, NC;
5AIDS Healthcare Foundation, Fort Lauderdale, FL; 6ViiV Healthcare, Durham, NC; 7ViiV Healthcare, London, UK; 8AIDS Healthcare Foundation, Miami, FL.






|
| |
|
 |
 |
|
|